Disruption of Specific RNA-RNA Interactions in a Double-Stranded RNA Virus Inhibits Genome Packaging and Virus Infectivity

PLoS Pathogens

Volumn 11, Issue 12, 2015, Pages

  Fajardo, Teodoro ^a   Sung, Po Yu ^a   Roy, Polly ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

OLIGORIBONUCLEOTIDE; VIRUS RNA;

ARTICLE; AUTORADIOGRAPHY; BLUETONGUE ORBIVIRUS; DNA PACKAGING; DOUBLE-STRANDED RNA VIRUS; GEL MOBILITY SHIFT ASSAY; IMMUNE RESPONSE; MUTAGENESIS; NONHUMAN; OPEN READING FRAME; PROTEIN RNA BINDING; PROTEIN SYNTHESIS; REVERSE GENETICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS INFECTIVITY; VIRUS REPLICATION; ANIMAL; GENETIC TRANSCRIPTION; GENETICS; HAMSTER; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOGENICITY; REOVIRUS INFECTION; SITE DIRECTED MUTAGENESIS; VIRUS ASSEMBLY; VIRUS GENOME;

ANIMALS; BASE SEQUENCE; BLUETONGUE VIRUS; CRICETINAE; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENOME, VIRAL; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; REOVIRIDAE INFECTIONS; RNA, VIRAL; TRANSCRIPTION, GENETIC; VIRUS ASSEMBLY; VIRUS REPLICATION;

EID: 84953339362     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005321     Document Type: Article

References (35)

1. Standfast HA, Dyce AL, Muller MJ, Vectors of bluetongue virus in Australia. Progress in clinical and biological research. 1985;178:177–86. 2989850.
2. Roy P, Bluetongue virus proteins. The Journal of general virology. 1992;73 (Pt 12):3051–64. 1335020.
3. Roy P, Bluetongue virus: dissection of the polymerase complex. The Journal of general virology. 2008;89(Pt 8):1789–804. doi: 10.1099/vir.0.2008/002089-0 18632949; PubMed Central PMCID: PMC2735681.
4. Matsuo E, Roy P, Bluetongue virus VP1 polymerase activity in vitro: template dependency, dinucleotide priming and cap dependency. PloS one. 2011;6(11):e27702. doi: 10.1371/journal.pone.0027702 22110731; PubMed Central PMCID: PMC3216989.
5. Boyce M, Wehrfritz J, Noad R, Roy P, Purified recombinant bluetongue virus VP1 exhibits RNA replicase activity. Journal of virology. 2004;78(8):3994–4002. 15047815; PubMed Central PMCID: PMC374272.
6. Lourenco S, Roy P, In vitro reconstitution of Bluetongue virus infectious cores. Proceedings of the National Academy of Sciences of the United States of America. 2011;108(33):13746–51. doi: 10.1073/pnas.1108667108 21808007; PubMed Central PMCID: PMC3158217.
7. Hyatt AD, Zhao Y, Roy P, Release of bluetongue virus-like particles from insect cells is mediated by BTV nonstructural protein NS3/NS3A. Virology. 1993;193(2):592–603. doi: 10.1006/viro.1993.1167 8384747.
8. Ratinier M, Caporale M, Golder M, Franzoni G, Allan K, Nunes SF, et al. Identification and characterization of a novel non-structural protein of bluetongue virus. PLoS pathogens. 2011;7(12):e1002477. doi: 10.1371/journal.ppat.1002477 22241985; PubMed Central PMCID: PMC3248566.
9. Yamakawa M, Krasnyck V, Roy P, Phylogenetic relationships of the VP2 protein of a virulent isolate of bluetongue virus (BTV-23) compared to those of 6 other BTV serotypes. Virus research. 1994;34(1):81–92. 7831967.
10. Sung PY, Roy P, Sequential packaging of RNA genomic segments during the assembly of Bluetongue virus. Nucleic acids research. 2014. doi: 10.1093/nar/gku1171 25428366.
11. Burkhardt C, Sung PY, Celma CC, Roy P, Structural constraints in the packaging of bluetongue virus genomic segments. The Journal of general virology. 2014;95(Pt 10):2240–50. doi: 10.1099/vir.0.066647-0 24980574; PubMed Central PMCID: PMC4165931.
12. Boyce M, Celma CC, Roy P, Development of reverse genetics systems for bluetongue virus: recovery of infectious virus from synthetic RNA transcripts. Journal of virology. 2008;82(17):8339–48. doi: 10.1128/JVI.00808-08 18562540; PubMed Central PMCID: PMC2519640.
13. Fournier E, Moules V, Essere B, Paillart JC, Sirbat JD, Isel C, et al. A supramolecular assembly formed by influenza A virus genomic RNA segments. Nucleic acids research. 2012;40(5):2197–209. doi: 10.1093/nar/gkr985 22075989; PubMed Central PMCID: PMC3300030.
14. Noda T, Genome Packaging Mechanism of Influenza A Virus. Yakugaku zasshi: Journal of the Pharmaceutical Society of Japan. 2015;135(9):1011–3. doi: 10.1248/yakushi.15-00175-2 26329545.
15. Trask SD, McDonald SM, Patton JT, Structural insights into the coupling of virion assembly and rotavirus replication. Nature reviews Microbiology. 2012;10(3):165–77. doi: 10.1038/nrmicro2673 22266782; PubMed Central PMCID: PMC3771686.
16. Kobayashi T, Antar AA, Boehme KW, Danthi P, Eby EA, Guglielmi KM, et al. A plasmid-based reverse genetics system for animal double-stranded RNA viruses. Cell host & microbe. 2007;1(2):147–57. doi: 10.1016/j.chom.2007.03.003 18005692; PubMed Central PMCID: PMC2034303.
17. Roner MR, Joklik WK, Reovirus reverse genetics: Incorporation of the CAT gene into the reovirus genome. Proceedings of the National Academy of Sciences of the United States of America. 2001;98(14):8036–41. doi: 10.1073/pnas.131203198 11427706; PubMed Central PMCID: PMC35463.
18. Gavazzi C, Yver M, Isel C, Smyth RP, Rosa-Calatrava M, Lina B, et al. A functional sequence-specific interaction between influenza A virus genomic RNA segments. Proceedings of the National Academy of Sciences of the United States of America. 2013;110(41):16604–9. doi: 10.1073/pnas.1314419110 24067651; PubMed Central PMCID: PMC3799358.
19. Gavazzi C, Isel C, Fournier E, Moules V, Cavalier A, Thomas D, et al. An in vitro network of intermolecular interactions between viral RNA segments of an avian H5N2 influenza A virus: comparison with a human H3N2 virus. Nucleic acids research. 2013;41(2):1241–54. doi: 10.1093/nar/gks1181 23221636; PubMed Central PMCID: PMC3553942.
20. Essere B, Yver M, Gavazzi C, Terrier O, Isel C, Fournier E, et al. Critical role of segment-specific packaging signals in genetic reassortment of influenza A viruses. Proceedings of the National Academy of Sciences of the United States of America. 2013;110(40):E3840–8. doi: 10.1073/pnas.1308649110 24043788; PubMed Central PMCID: PMC3791739.
21. Gerber M, Isel C, Moules V, Marquet R, Selective packaging of the influenza A genome and consequences for genetic reassortment. Trends in microbiology. 2014;22(8):446–55. doi: 10.1016/j.tim.2014.04.001 24798745.
22. Watanabe T, Watanabe S, Noda T, Fujii Y, Kawaoka Y, Exploitation of nucleic acid packaging signals to generate a novel influenza virus-based vector stably expressing two foreign genes. Journal of virology. 2003;77(19):10575–83. 12970442; PubMed Central PMCID: PMC228515.
23. Huiskonen JT, de Haas F, Bubeck D, Bamford DH, Fuller SD, Butcher SJ, Structure of the bacteriophage phi6 nucleocapsid suggests a mechanism for sequential RNA packaging. Structure. 2006;14(6):1039–48. doi: 10.1016/j.str.2006.03.018 16765897.
24. Gao Q, Palese P, Rewiring the RNAs of influenza virus to prevent reassortment. Proceedings of the National Academy of Sciences of the United States of America. 2009;106(37):15891–6. doi: 10.1073/pnas.0908897106 19805230; PubMed Central PMCID: PMC2747214.
25. Gu S, Ji J, Kim JD, Yee JK, Rossi JJ, Inhibition of infectious human immunodeficiency virus type 1 virions via lentiviral vector encoded short antisense RNAs. Oligonucleotides. 2006;16(4):287–95. doi: 10.1089/oli.2006.16.287 17155905.
26. Rosas MF, Martinez-Salas E, Sobrino F, Stable expression of antisense RNAs targeted to the 5' non-coding region confers heterotypic inhibition to foot-and-mouth disease virus infection. The Journal of general virology. 2003;84(Pt 2):393–402. 12560572.
27. Yang B, Lan X, Li X, Yin X, Li B, Han X, et al. A novel bi-functional DNA vaccine expressing VP1 protein and producing antisense RNA targeted to 5'UTR of foot-and-mouth disease virus can induce both rapid inhibitory effect and specific immune response in mice. Vaccine. 2008;26(43):5477–83. doi: 10.1016/j.vaccine.2008.07.060 18694793.
28. Wu Y, Zhang G, Li Y, Jin Y, Dale R, Sun LQ, et al. Inhibition of highly pathogenic avian H5N1 influenza virus replication by RNA oligonucleotides targeting NS1 gene. Biochemical and biophysical research communications. 2008;365(2):369–74. doi: 10.1016/j.bbrc.2007.10.196 17996729.
29. Fajardo T, Jr.Rosas MF, Sobrino F, Martinez-Salas E, Exploring IRES region accessibility by interference of foot-and-mouth disease virus infectivity. PloS one. 2012;7(7):e41382. doi: 10.1371/journal.pone.0041382 22815996; PubMed Central PMCID: PMC3399821.
30. Kierzek R, Turner DH, Kierzek E, Microarrays for identifying binding sites and probing structure of RNAs. Nucleic acids research. 2015;43(1):1–12. doi: 10.1093/nar/gku1303 25505162.
31. Kierzek E, Binding of short oligonucleotides to RNA: studies of the binding of common RNA structural motifs to isoenergetic microarrays. Biochemistry. 2009;48(48):11344–56. doi: 10.1021/bi901264v 19835418.
32. Weiner MP, Costa GL, Schoettlin W, Cline J, Mathur E, Bauer JC, Site-directed mutagenesis of double-stranded DNA by the polymerase chain reaction. Gene. 1994;151(1–2):119–23. 7828859.
33. Ferrandon D, Koch I, Westhof E, Nusslein-Volhard C, RNA-RNA interaction is required for the formation of specific bicoid mRNA 3' UTR-STAUFEN ribonucleoprotein particles. The EMBO journal. 1997;16(7):1751–8. doi: 10.1093/emboj/16.7.1751 9130719; PubMed Central PMCID: PMC1169778.
34. Ramos R, Martinez-Salas E, Long-range RNA interactions between structural domains of the aphthovirus internal ribosome entry site (IRES). Rna. 1999;5(10):1374–83. 10573128; PubMed Central PMCID: PMC1369859.
35. Matsuo E, Roy P, Bluetongue virus VP6 acts early in the replication cycle and can form the basis of chimeric virus formation. Journal of virology. 2009;83(17):8842–8. doi: 10.1128/JVI.00465-09 19553329; PubMed Central PMCID: PMC2738189.